Methylene Blue Cation

Methylene Blue Cation

SCHEMBL128584

[13CH3]N([13CH3])c1ccc2nc3ccc(N([13CH3])[13CH3])cc3[s+]c2c1

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GUCY1A1GUCY1A2GUCY1B1GUCY1B2

The experimentally established mechanism targets of Methylene Blue Cation. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 5/20 0.57
TERT O14746 1/20 0.57
APAF1 O14727 2/20 0.47
EGFR P00533 2/20 0.46
PSMB5 P28074 5/20 0.42
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
ALDH1A1 P00352 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
ELANE P08246 1/20 0.39
IP6K1 Q92551 1/20 0.39
INSR P06213 1/20 0.38
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
GSR P00390 1/20 0.36
POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methylene Blue Cation SCHEMBL12312498 1.00 APP (0.57) APPTERTAPAF1EGFRPSMB5
Methylene Blue Cation SCHEMBL12312497 1.00 APP (0.57) APPTERTAPAF1EGFRPSMB5
Methylene Blue Cation SCHEMBL109755 1.00 APP (0.57) APPTERTAPAF1EGFRPSMB5
Methylene Blue Cation SCHEMBL29941578 1.00 APP (0.57) APPTERTAPAF1EGFRPSMB5
Methylene Blue Cation SCHEMBL12312491 1.00 APP (0.57) APPTERTAPAF1EGFRPSMB5
Methylene Blue Cation SCHEMBL4565666 0.98 APP (0.55) APPTERTAPAF1EGFRPSMB5
Methylene Blue Cation SCHEMBL1926028 0.98 APP (0.55) APPTERTAPAF1EGFRPSMB5
Methylene Blue Cation SCHEMBL1351 0.98 APP (0.55) APPTERTAPAF1EGFRPSMB5
Methylene Blue Cation SCHEMBL1461350 0.98 APP (0.55) APPTERTAPAF1EGFRPSMB5
Methylene Blue Cation SCHEMBL1207285 0.98 APP (0.55) APPTERTAPAF1EGFRPSMB5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8440821-B2 Methods of synthesis and/or purification of diaminophenothiazinium compounds WISTA LABORATORIES LTD. (SG) 2013-05-14 US disclosed
US-8263589-B2 Inhibitors of protein aggregation WISTA LABORATORIES LTD. (SG) 2012-09-11 US disclosed
US-20120058995-A1 METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INVOLVING THE USE OF PERSULFATE OXIDANTS WISTA LABORATORIES LTD. (SG) 2012-03-08 US disclosed
US-20110294795-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS WISTA LABORATORIES LTD. 2011-12-01 US disclosed
US-20110021510-A1 METHODS OF CHEMICAL SYNTHESIS AND PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) WISTA LABORATORIES LTD. 2011-01-27 US disclosed
US-7790881-B2 Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC) WISTA LABORATORIES LTD. (SG) 2010-09-07 US disclosed
US-20090209526-A1 INHIBITORS OF PROTEIN AGGREGATION WISTA LABORATORIES LTD 2009-08-20 US disclosed
US-20080207603-A1 Methods of Chemical Synthesis and Purification of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc) WISTA LABORATORIES LTD. 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209526-A1 INHIBITORS OF PROTEIN AGGREGATION SNCA, PARK7, HTT APP 26/4885TERT 2153/4885APAF1 676/4885
US-20080207603-A1 Methods of Chemical Synthesis and Purification of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc) MGMT, MAPT, CRBN APP 102/4885TERT 10/4885APAF1 1370/4885
US-20120058995-A1 METHODS OF CHEMICAL SYNTHESIS OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INVOLVING THE USE OF PERSULFATE OXIDANTS TST, TPMT, MGMT APP 18/4885TERT 61/4885APAF1 1600/4885
US-20110294795-A1 METHODS OF SYNTHESIS AND/OR PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS MMAB, MB, ABCB7 APP 3144/4885TERT 743/4885APAF1 3986/4885
US-20110021510-A1 METHODS OF CHEMICAL SYNTHESIS AND PURIFICATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS INCLUDING METHYLTHIONINIUM CHLORIDE (MTC) MGMT, TST, MAPT APP 110/4885TERT 11/4885APAF1 1073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.